We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGO
1251
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$2K ﹤0.01%
98
FMTX
1252
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2K ﹤0.01%
162
ENDP
1253
DELISTED
Endo International plc
ENDP
$2K ﹤0.01%
800
INBX
1254
DELISTED
Inhibrx, Inc. Common Stock
INBX
$2K ﹤0.01%
111
ABUS icon
1255
Arbutus Biopharma
ABUS
$847M
$1K ﹤0.01%
395
ACIU icon
1256
AC Immune
ACIU
$231M
$1K ﹤0.01%
158
ADMA icon
1257
ADMA Biologics
ADMA
$2.02B
$1K ﹤0.01%
+586
New +$914
ALLK
1258
DELISTED
Allakos
ALLK
$1K ﹤0.01%
158
ALT icon
1259
Altimmune
ALT
$568M
$1K ﹤0.01%
136
ANAB icon
1260
AnaptysBio
ANAB
$1.54B
$1K ﹤0.01%
60
LONA
1261
LeonaBio Inc
LONA
$66.1M
$1K ﹤0.01%
11
AVDL
1262
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
120
JBIO
1263
Jade Biosciences
JBIO
$1.18B
$1K ﹤0.01%
+2
New +$776
BCAB icon
1264
BioAtla
BCAB
$5.34M
$1K ﹤0.01%
2
BLUE
1265
DELISTED
bluebird bio
BLUE
$1K ﹤0.01%
12
CGEM icon
1266
Cullinan Oncology
CGEM
$1.06B
$1K ﹤0.01%
127
CGEN icon
1267
Compugen
CGEN
$212M
$1K ﹤0.01%
156
CMPS
1268
Compass Pathways
CMPS
$1.47B
$1K ﹤0.01%
64
COGT icon
1269
Cogent Biosciences
COGT
$6.76B
$1K ﹤0.01%
116
CRIS icon
1270
Curis
CRIS
$9.71M
$1K ﹤0.01%
1
DBX icon
1271
PUT
Dropbox
DBX
$7.78B
$1K ﹤0.01%
+1,000
New +$23.3K
DTIL icon
1272
Precision BioSciences
DTIL
$178M
$1K ﹤0.01%
7
DYN icon
1273
Dyne Therapeutics
DYN
$4.15B
$1K ﹤0.01%
150
EWTX icon
1274
Edgewise Therapeutics
EWTX
$4.28B
$1K ﹤0.01%
144
EYPT icon
1275
EyePoint Inc
EYPT
$999M
$1K ﹤0.01%
99

Similar funds

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.